Keppra (Levetiracetam)
0098627
 
Ordering Recommendation
Mnemonic
KEPPRA
Methodology
Quantitative Enzyme Immunoassay
Performed
Sun-Sat
Reported
Within 24 hours
New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation
Timing of specimen collection: Pre-dose (trough) draw - At steady state concentration.  
Collect
Plain red. Also acceptable: Lavender (EDTA), pink (K2EDTA), or green (sodium or lithium heparin).  
Specimen Preparation
Separate serum or plasma from cells ASAP or within 2 hours of collection. Transfer 1 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.3 mL)  
Storage/Transport Temperature
Refrigerated.  
Unacceptable Conditions
Serum or plasma separator tubes. Grossly hemolyzed specimens.  
Remarks
 
Stability
After separation from cells: Ambient: 6 days; Refrigerated: 1 week; Frozen: 1 month  
Reference Interval
Effective November 18, 2013

Therapeutic range: 12-46 µg/mL
Toxic: Not well established
Interpretive Data
Pharmacokinetics of levetiracetam are affected by renal function. Adverse effects may include somnolence, weakness, headache and vomiting.
Note
CPT Code(s)
80177
Components
Component Test Code*Component Chart Name
0098627Keppra (Levetiracetam)
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, contact interface support at interface.support@aruplab.com.
Cross References
  • anti-epileptic
  • Keppra
  • keppra blood concentration
  • Keppra concentration
  • Keppra level, Keppra blood level
  • Levetiracetam